Vitamin D3 Dosage for Indian Adults
For Indian adults, use 60,000 IU cholecalciferol monthly during summer months and 120,000 IU monthly during winter months for maintenance, or for treating deficiency, give 50,000 IU weekly for 8 weeks followed by maintenance of 1500-2000 IU daily. 1
Context: Why Indians Need Special Consideration
The Indian population has an exceptionally high prevalence of vitamin D deficiency—studies show 83-85% of apparently healthy Indians have serum 25(OH)D levels below 20 ng/mL, despite abundant sunlight 2, 3, 4. This paradox occurs due to skin pigmentation, cultural clothing practices, indoor lifestyles, and dietary patterns. The 2024 Endocrine Society guidelines note that most vitamin D trials in Asia highlight the need for population-specific approaches 5.
Treatment Algorithm for Vitamin D Deficiency
For Confirmed Deficiency (25(OH)D < 20 ng/mL):
Initial Treatment Phase (8 weeks):
- 50,000 IU cholecalciferol once weekly for 8 weeks 1
- Alternative: 6,000 IU daily for 8 weeks (equivalent dosing) 1
- Target: Achieve 25(OH)D > 30 ng/mL
Maintenance Phase (after correction):
- 1,500-2,000 IU daily 1
- This maintains levels above 30 ng/mL in most adults
For Maintenance Without Known Deficiency:
Seasonal Dosing Strategy (Indian-specific evidence):
This seasonal approach is supported by Indian research showing that 60,000 IU monthly suffices during summer (when baseline levels naturally rise from 4.5 to 10.8 ng/mL even without supplementation), but higher doses are needed in winter to maintain adequate levels 3.
Alternative Daily Dosing:
Special Populations Requiring Higher Doses
Obese patients, malabsorption syndromes, or patients on medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids, ketoconazole, AIDS medications):
The Endocrine Society explicitly recommends 2-3 times higher doses for these groups 1.
Critical Pitfalls to Avoid
Don't use standard "calcium tablet" doses: The 250 IU per 500 mg calcium carbonate commonly available in India is grossly inadequate—only 4.7% of subjects achieved sufficiency with this approach versus 66.7% with 1,000 IU daily 4.
Don't give massive single bolus doses: While 60,000 IU monthly is safe and effective, avoid single doses exceeding 300,000 IU due to hypercalcemia risk, particularly in children 1.
Monitor for non-responders: If 25(OH)D doesn't rise after 50,000 IU weekly for 8 weeks, evaluate for celiac disease or cystic fibrosis 1.
Don't skip maintenance: Indian research shows that after a single 60,000 IU dose, levels peak at 1 month (18.7 ng/mL) but decline to 11.1 ng/mL by month 3, demonstrating the need for ongoing supplementation 2.
Safety Considerations
The regimens above are safe with minimal adverse events. In the largest Indian trial, only 3 of 100 subjects developed transient hypercalciuria (2 on 2,000 IU daily, 1 on 60,000 IU monthly), with no hypercalcemia 6. The Endocrine Society confirms no significant safety concerns with these doses for several years 5.
Upper limits without medical supervision: 4,000 IU daily for adults over age 8, though up to 10,000 IU daily may be needed to correct deficiency 1.
Practical Implementation
Either vitamin D2 or D3 is acceptable 1, though D3 (cholecalciferol) is preferred based on the evidence base.
Monthly dosing improves compliance compared to daily regimens, particularly relevant in resource-limited settings 2, 3. The monthly 60,000-120,000 IU approach is uniquely validated in Indian populations and represents a pragmatic, evidence-based strategy for this high-risk population.